Name | DCC-3014 |
---|
Description | DCC-3014 is a c-FMS (CSF-IR) and c-Kit dual inhibitor extracted from patent WO2014145025A2, Compound Example 10, has IC50s of <0.01 μM and 0.1-1 μM, respectively[1]. |
---|---|
Related Catalog | |
Target |
IC50: <0.01 μM (c-FMS/CSF-IR), 0.1-1 μM (c-Kit)[1] |
In Vitro | DCC-3014 is a c-FMS (CSF-IR) and c-Kit dual inhibitor with anti-cancer and anti-proliferative activities[1]. |
References |
Molecular Formula | C23H25N7O2 |
---|---|
Molecular Weight | 431.49 |